Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Activation of the P-TEFb Complex by Lethal Prostate Cancer-Associated Enhancer RNAs
PubMed Full text in PMC Similar studies
Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in androgen deprivation conditions [ChIP-Seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Activation of P-TEFb by enhancer RNAs associated with lethal prostate cancer [ChIP-seq]
Activation of the P-TEFb Complex by Lethal Prostate Cancer-Associated Enhancer RNAs [ChIP-Seq]
Activation of the P-TEFb Complex by Lethal Prostate Cancer-Associated Enhancer RNAs [RNA-Seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in Castration-Resistant Prostate Cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
Profiles of prostate cancer cell lines
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide
Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth
PubMed Similar studies Analyze with GEO2R
Linking prostate cancer cell AR heterogeneity to distinct castration and Enzalutamide responses
Expression data from LNCaP cells treated with DHT and enzalutamide
Ligand-independent CXCR7 Activation of MAPK Signaling leads to Prostate Cancer Enzalutamide Resistance
Transcriptional responses of control and MDV3100 resistant lines to DMSO or MDV3100
Testing rescue of AR signaling by ectopic expression of mutant AR allele in the presence of MDV-3100
Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq]
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [ChIP-seq]
J_093015-circRNA-33 AS-CR-005 Human CircRNA V2 microarray 01272016
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on